Eton Pharmaceuticals, Inc. - Common Stock (ETON)

CUSIP: 29772L108

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / Common Stock
Shares outstanding
26,828,643
Total 13F shares
1,767,833
Share change
+266,750
Total reported value
$13,965,000
Price per share
$7.90
Number of holders
10
Value change
+$2,101,428
Number of buys
7
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 29772L108?
CUSIP 29772L108 identifies ETON - Eton Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Eton Pharmaceuticals, Inc. - Common Stock (ETON) as of Q2 2019

As of 30 Jun 2019, Eton Pharmaceuticals, Inc. - Common Stock (ETON) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,767,833 shares. The largest 10 holders included Opaleye Management Inc., AWM Investment Company, Inc., Diametric Capital, LP, PRELUDE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, BlackRock Inc., WELLS FARGO & COMPANY/MN, Tower Research Capital LLC (TRC), MORGAN STANLEY, and UBS Group AG. This page lists 10 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.